OpenAI Researcher Miles Wang Launches AI Drug Discovery Startup, Raising $200M at $2B Valuation
According to TechCrunch, OpenAI researcher Miles Wang is founding an AI-focused biotech startup for drug discovery, raising approximately $200 million at a $2 billion valuation. Lightspeed Venture Partners may lead the funding round.
The startup plans to develop AI models for identifying new
GateNews·07-15 11:01
